1. Home
  2. ICCC vs ALAR Comparison

ICCC vs ALAR Comparison

Compare ICCC & ALAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • ALAR
  • Stock Information
  • Founded
  • ICCC 1982
  • ALAR 2013
  • Country
  • ICCC United States
  • ALAR Israel
  • Employees
  • ICCC N/A
  • ALAR N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • ALAR Computer Software: Prepackaged Software
  • Sector
  • ICCC Health Care
  • ALAR Technology
  • Exchange
  • ICCC Nasdaq
  • ALAR Nasdaq
  • Market Cap
  • ICCC 47.4M
  • ALAR 45.3M
  • IPO Year
  • ICCC 1987
  • ALAR 2018
  • Fundamental
  • Price
  • ICCC $5.20
  • ALAR $7.36
  • Analyst Decision
  • ICCC
  • ALAR Strong Buy
  • Analyst Count
  • ICCC 0
  • ALAR 1
  • Target Price
  • ICCC N/A
  • ALAR $11.00
  • AVG Volume (30 Days)
  • ICCC 22.3K
  • ALAR 96.2K
  • Earning Date
  • ICCC 05-14-2025
  • ALAR 05-29-2025
  • Dividend Yield
  • ICCC N/A
  • ALAR N/A
  • EPS Growth
  • ICCC N/A
  • ALAR N/A
  • EPS
  • ICCC N/A
  • ALAR 0.08
  • Revenue
  • ICCC $26,493,169.00
  • ALAR $31,824,000.00
  • Revenue This Year
  • ICCC N/A
  • ALAR N/A
  • Revenue Next Year
  • ICCC N/A
  • ALAR $12.28
  • P/E Ratio
  • ICCC N/A
  • ALAR $8.37
  • Revenue Growth
  • ICCC 51.63
  • ALAR 20.00
  • 52 Week Low
  • ICCC $3.34
  • ALAR $5.45
  • 52 Week High
  • ICCC $5.82
  • ALAR $46.69
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 47.84
  • ALAR 55.74
  • Support Level
  • ICCC $5.01
  • ALAR $6.62
  • Resistance Level
  • ICCC $5.72
  • ALAR $7.15
  • Average True Range (ATR)
  • ICCC 0.18
  • ALAR 0.43
  • MACD
  • ICCC -0.04
  • ALAR 0.02
  • Stochastic Oscillator
  • ICCC 37.50
  • ALAR 75.54

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.

Share on Social Networks: